US 10093742
Multispecific GITR-binding fusion proteins and methods of use thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 10093742 (Multispecific GITR-binding fusion proteins and methods of use thereof) held by Inhibrx, Inc. expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inhibrx, Inc.
- Grant date
- Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 57
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00